| Just Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Personal Finance > Why the Personal Savings Rate is so Low: The Untold Story |
|
Just Articles - Why the Personal Savings Rate is so Low: The Untold Story
I am reminded about the phase “there’s no money in truth”. I mention this on the heels of an AP news article January 30, 2006 declaring that personal s According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product avings have not been as low as they are today since the period of 1932-33 during The Great Depression. The Department of Commerce recently released dat ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in indicating personal savings, once nearly 11% in 1984, plummeted to 0.5% in 2005. Said another way, people are spending more than their after-tax earni lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. gs and no doubt using credit to fill the gaps. The article goes on to point the finger for this disconcerting fact to American complacency as per high here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe real estate prices (paper wealth) and general over consumption. With 78% of baby-boomer Americans turning the corner towards retirement, the negative d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ate of savings is alarming. According to Lyle Gramley, senior economic advisor at Schwab Washington Research Group,"Americans have been content to spen ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc a lot more than is good for them or for the economy”. Interestingly, the AP article never once mentioned the impact skyrocketing cost of living for l easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ife’s basics: health insurance, mortgages, rents, groceries, higher education, child care, home heating, etc., was having on the ability to save any m nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ney. This fact alone pushes families to the edge and often over the edge of their budgets as they are forced to make some difficult choices. Now for t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e “there’s no money in truth” part of this article. Ever notice how we the “consumer” are always the ones at fault for the glaring financial challenges ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi so many people face these days? What’s worse, most everyone agrees. It’s like in the Emperor’s New Clothes where everyone agrees that the emperor is we ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a aring the finest garments. But is he really? Similarly, are we alone, as individuals, responsible for the personal finance crisis that currently affect dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod millions? I don’t think so. There’s seldom a shred of accountability from the financial industry and advertisers in general when it comes to the blat cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin nt selling of emotional propaganda such as “ Live Richly” and “have it all now”. Their version of happiness and success is the one most often subscrib tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ed to. How do experts like Lyle Gramley think we “consumers’ came to cultivate our attitudes and spending styles in the first place? Not to mention, d t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel n’t even think of taking a look at the structure of the monetary system itself. You could discover that its system design has a direct affect on the a ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust erage American’s ability to put some money away. Heaven forbid. That would be biting the hand that feeds you! Throughout history, change agents have k y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nown effective and permanent change in any sphere of life requires review and adjustment at a systemic level. As regards the financial conundrum of mor . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de money going out than coming in on a mass societal level, the same thing holds true. Until we each are willing to consider the critical systemic compo elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ent to this snowballing financial crisis, one thing is certain: Behind closed doors, people will continue to believe they have only themselves to blame tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Using Credit Cards To Rebuild Credit - Tips for Credit Repair Forex Trading - 6 Simple Tips To Increase Your Profit Potential How to Reduce Your Debt Without Getting a Debt Consolidation Loan
|